3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
46
Recurrence
6
Leukemia, Myeloid, Acute
5
Waldenstrom Macroglobulinemia
2
Smoldering Multiple Myeloma
2
Plasmacytoma
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoglobulin Light-chain Amyloidosis
2
Carcinoma, Non-Small-Cell Lung
2
Various Advanced Cancer
1
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypergammaglobulinemia
1
Hodgkin Disease
1
Amyloidosis
1
Interventions
fludarabine phosphate
23
Peripheral Blood Stem Cell Transplantation
19
Whole-Body Irradiation
18
Mycophenolic Acid
16
Cyclophosphamide
15
Busulfan
15
Tacrolimus
14
Antilymphocyte Serum
14
Cyclosporine
11
Melphalan
10
Rituximab
9
Methotrexate
9
Etoposide
8
romidepsin
6
Flow Cytometry
6
Filgrastim
6
Vorinostat
5
Dexamethasone
5
thymoglobulin
4
fludarabine
4
Sirolimus
4
Granulocyte Colony-Stimulating Factor
4
Carboplatin
4
Calcium Dobesilate
4
Bexarotene
4
Alemtuzumab
4
Thiotepa
3
Therapeutics
3
Radiotherapy
3
Panobinostat
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell, Cutaneous
×
daratumumab
×
Clear all
No trials found.